ArticleGalen medical journal2025
Exploring CYP17 Gene Polymorphism as a Predictive Marker in Iraqi Women with Polycystic Ovary Syndrome and Its Association with Hormonal Dysregulation : CYP17A1 Polymorphism in Iraqi women with PCOS.
Article in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although most women of reproductive age diagnosed with polycystic ovary syndrome (PCOS) represent a common disorder with significant long-term health implications. Investigations on the CYP17A1 gene, which plays a pivotal role in androgen biogenesis, explored its potential role as a predictive marker for the risk of PCOS. This research was conducted to evaluate the association of CYP17A1 polymorphism (rs743572 variant) with susceptibility to polycystic ovarian syndrome (PCOS) among the Iraqi population. Materials and Methods: We executed a case-control study consisting of 66 PCOS patients and 74 controls. Restriction Fragment Length Polymorphism (RFLP) was used to detect the genotypes. Results: The TT genotype of CYP17A1 was significantly associated with an increased risk of PCOS, with an approximately fourfold higher odds of developing PCOS versus the CC genotype. No significant increase in risk was seen for the CT genotype. The TT polymorphism of CYP17A1 (rs743572) was significantly associated with PCOS (adjusted OR=3.97, P=0.03), while the CT variant showed a non-significant trend, after adjusting for age and BMI. Conclusion: The current study, by providing further evidence for the association between CYP17A1 genetic polymorphisms and PCOS in multi-ethnic populations, has important implications for the management of this complex disorder, indicating the potential use of genotyping in assessing the genetic risk of the disorder in different ethnic groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.